Smoking Abstinence Clinical Trial
Official title:
Boosting Chinese Healthcare Service Providers' Utilization of Behavioral and Pharmacotherapy Interventions for Cigarette Smoking Cessation by 'WeChat WeQuit' Program
In this single-blind, randomized trial, undertaken in China with 8-week interventions and follow-up to 52 weeks, about 2,200 providers will be randomly allocated to the intervention or control group.
Previous studies have been showed that providing behavioral and pharmacotherapy interventions
for cigarette smoking patients was effective but rare among Chinese healthcare service
providers. In order to minimize the huge gap between the shortage and demand for smoking
cessation training program and smoking cessation service, this 'WeChat WeQuit' smoking
cessation training program has been designed to assess whether it will increase Chinese
healthcare service providers' utilization of behavioral and pharmacotherapy interventions for
cigarette smoking cessation or not.
In this single-blind, randomized trial, about 2200 HSPs will be randomly selected (by
randomizeR, https://CRAN.R-project.org/package=randomizeR) to 8-week intervention (behavioral
and pharmacotherapy interventions for cigarette smoking patients to help them quit smoking)
group or control group that only communicates without any standard smoking cessation
practices related messages, and follow-up to 52 weeks. The trial will be carried out in into
two phases, the first phase is the pilot study (n=200, 8-week intervention and follow-up to
16 weeks) and the second is the main study (n=2000, 8-week intervention and follow-up to 52
weeks). It is hypothesized that 'WeChat WeQuit' training program will improve Chinese HSPs'
utilization of behavioral and pharmacotherapy interventions for cigarette smoking cessation
and increase quit rate for smoking patients.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00414752 -
Effects of AFQ056 and Nicotine in Reducing Cigarette Smoking
|
Phase 1 | |
| Completed |
NCT05385055 -
Reduction of Exposure, Inflammation, and Oxidative Stress Following at Least 2 Years of Switching to THS Use Compared to Cigarette Smoking
|
||
| Completed |
NCT01210586 -
Tobacco Cessation in Postmenopausal Women
|
N/A | |
| Enrolling by invitation |
NCT05382221 -
Breathe 2 Project 3: Comprehensive Chronic Care
|
N/A |